Search Results - "Yuen, Yi Ching"

Targeted therapy at the end of life in advanced cancer patients by Soh, Thomas I Peng, Yuen, Yi-Ching, Teo, Catherine, Lim, Siew-Woon, Chan, Noreen, Wong, Alvin Seng Cheong

“…We describe the use of systemic therapy in advanced cancer patients admitted to an acute care hospital, with a focus on targeted therapy. We aim to spotlight…”
Get more information

The alternative lengthening of telomeres pathway may operate in non-neoplastic human cells by Slatter, Tania L, Tan, Xin, Yuen, Yi Ching, Gunningham, Sarah, Ma, Sally SiYan, Daly, Erin, Packer, Stephen, Devenish, Celia, Royds, Janice A, Hung, Noelyn A

“…The alternative lengthening of telomeres (ALT) mechanism represents an alternative to the enzyme telomerase in the maintenance of mammalian telomeres in 25–60%…”
Get full text

A Non-Coding Variant in LOC105371512 Confers Susceptibility to Bleomycin-Induced Lung Injury by Lee, Joanne, Tabatabaeian, Hossein, Poon, Michelle Limei, Somasundaram, Nagavalli, Xin, Liu, Yuen, Yi Ching, Teoh, Chia Meng, Yan, Benedict, Chan, Esther Hian Li, Chee, Yen Lin, De Mel, Sanjay, Zhang, Bin, Chew, Xiao Hong, Tang, Tiffany, Khor, Chiea Chuen, Ngeow, Joanne Yuen Yie, Ong, Choon Kiat, Lim, Soon Thye, Chng, Wee Joo, Tai, E Shyong, Ngiam, Kee Yuan, Lee, Soo Chin, Goh, Boon Cher, Jeyasekharan, Anand Devaprasath D., Tay, Yvonne, Aminkeng, Folefac

Get full text

An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma by Goh, Jasmine, De Mel, Sanjay, Hoppe, Michal M, Mohd Abdul Rashid, Masturah Bte, Zhang, Xi Yun, Jaynes, Patrick, Ka Yan Ng, Esther, Rahmat, Nur'Atiqa Diana Binti, Jayalakshmi, Liu, Clementine Xin, Poon, Limei, Chan, Esther, Lee, Joanne, Chee, Yen Lin, Koh, Liang Piu, Tan, Lip Kun, Soh, Teck Guan, Yuen, Yi Ching, Loi, Hoi-Yin, Ng, Siok-Bian, Goh, Xueying, Eu, Donovan, Loh, Stanley, Ng, Sheldon, Tan, Daryl, Cheah, Daryl Ming Zhe, Pang, Wan Lu, Huang, Dachuan, Ong, Shin Yeu, Nagarajan, Chandramouli, Chan, Jason Yongsheng, Ha, Jeslin Chian Hung, Khoo, Lay Poh, Somasundaram, Nagavalli, Tang, Tiffany, Ong, Choon Kiat, Chng, Wee-Joo, Lim, Soon Thye, Chow, Edward K, Jeyasekharan, Anand D

“…Although combination therapy is the standard of care for relapsed/refractory non-Hodgkin's lymphoma (RR-NHL), combination treatment chosen for an individual…”
Get more information

Clinical Application of an Ex-Vivo Platform to Guide the Choice of Drug Combinations in Relapsed/Refractory Lymphoma; A Prospective Study by De Mel, Sanjay, Goh, Jasmine, Rashid, Masturah, Hoppe, Michal, Zhang, Xi Yun, Jaynes, Patrick, Ng, Esther KY, Rahmat, Nur Atiqa Diana Binte, Liu, Xin, Poon, Michelle, Chan, Hian Li Esther, Lee, Joanne, Chee, Yen-Lin, Koh, Liang Piu, Tan, Lip Kun, Soh, Teck Guan, Yuen, Yi Ching, Loi, Hoi Yin, Ng, Siok Bian, Goh, Xueying, Tan, Daryl, Cheah, Daryl Ming Zhe, Pang, Wan Lu, Huang, Dachuan, Somasundaram, Nagavalli, Tang, Tiffany, Chan, Jason Yongsheng, Lim, Soon Thye, Ong, Choon Kiat, Chng, Wee Joo, Chow, Edward KH, Jeyasekharan, Anand

“…Introduction While combination therapy is the standard of care for relapsed/ refractory non-Hodgkin lymphoma (RR-NHL), the choice of combinations for an…”
Get full text

Immunophenotypic and Genetic Characteristics of Diffuse Large B-Cell Lymphoma (DLBCL), and Prognostic Significance of Cell of Origin (COO) in a Southeast Asian Cohort by Chong, Vanessa CL, Yap, Eng Soo, Xin, Liu, Chin, Suk Teng, Jeyasekharan, Anand, Chee, Yen-Lin, Chan, Hian Li Esther, De Mel, Sanjay, Lee, Joanne Shu Xian, Lee, Yee Mei, Yuen, Yi Ching, Koh, Liang Piu, Poon, Michelle

“…BACKGROUND/OBJECTIVE: DLBCL is a heterogeneous disease which on gene expression profiling studies (GEP) can be divided into 2 distinct subtypes, germinal…”
Get full text

Paediatric-Inspired Acute Lymphoblastic Leukemia Protocols, Are They Too Toxic for Young Adults? by Ooi, Melissa G., Chng, Wee J, Ng, Chin-Hin, Yuen, Yi Ching, Yeoh, Allen Eng Juh, Hui, Chiew Kean, Seah, Elaine

“…BACKGROUND In children with acute lymphoblastic leukemia, (ALL), current therapies yield complete remission (CR) rates of 98% and event-free survival (EFS)…”
Get full text

Pharmacogenomic Prediction of Bleomycin-Induced Pneumonitis in South East Asian Hodgkin Lymphoma Patients by Lee, Joanne Shu Xian, Poon, Li Mei, Liu, Xin, Yuen, Yi Ching, Somasundaram, Nagavalli, Chin, Suk Teng, Teoh, Chia Meng, Yan, Benedict, Chan, Hian Li Esther Hian Li, Chee, Yen-Lin, Tang, Tiffany, Farzana, Noorul, Aw, Caroline Hui Ting, Khor, Chiea Chuen, Ngeow, Joanne Yuen Yie, Ong, Choon Kiat, Tai, E Shyong, Chng, Wee Joo, Goh, Boon Cher, Lee, Soo Chin, Aminkeng, Folefac

“…Background Hodgkin lymphoma (HL) accounts for 15% of all cancer diagnosis in young adults. Standard of care is ABVD (Adriamycin, Bleomycin, Vinblastine,…”
Get full text

Prolonged argatroban clearance in a critically ill patient with heparin-induced thrombocytopaenia by Tee, Caroline, Yuen, Yi Ching, Lim, Cheryl, Yap, Eng Soo

“…This is a case of argatroban use in a critically ill patient with heparin-induced thrombocytopaenia (HIT), presenting with unexpectedly prolonged drug…”
Get full text

Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma by de Mel, Sanjay, Rashid, Masturah B. M., Zhang, Xi Yun, Goh, Jasmine, Lee, Chun Tsu, Poon, Li Mei, Chan, Esther H. L., Liu, Xin, Chng, Wee Joo, Chee, Yen Lin, Lee, Joanne, Yuen, Yi Ching, Lim, Jing Quan, Chia, Burton K. H., Laurensia, Yurike, Huang, DaChuan, Pang, Wan Lu, Cheah, Daryl Ming Zhe, Wong, Esther Kam Yin, Ong, Choon Kiat, Tang, Tiffany, Lim, Soon Thye, Ng, Siok Bian, Tan, Soo Yong, Loi, Hoi-Yin, Tan, Lip Kun, Chow, Edward K., Jeyasekharan, Anand D.

Get full text

Drug use evaluation of transdermal fentanyl in a tertiary hospital by Yuen, Yi Ching, Wan, Mei Qi, Tan, Jun Hao, Chan, Noreen

“…ObjectivesThe primary objective of the study was to assess the rationale of fentanyl patch initiation and continuation for pain. The secondary objectives were…”
Get full text

Pegylated Filgrastim Versus Filgrastim for Stem Cell Mobilization in Multiple Myeloma After Novel Agent Induction by Abid, Muhammad Bilal, De Mel, Sanjay, Abid, Muhammad Abbas, Yap, Eng Soo, Gopalakrishnan, Sathish Kumar, Chen, Yunxin, Yuen, Yi Ching, Wong, Hung Chew, Lin, Adeline, Poon, Li Mei, Koh, Liang Piu, Chng, Wee Joo, Tan, Lip Kun

“…The current standard of care for transplant-eligible multiple myeloma (MM) patients is novel agent-based (NA) induction followed by high-dose chemotherapy and…”
Get full text

Identification and quantification of medication returned to Otago pharmacies by Braund, Rhiannon, Yuen, Yi-Ching, Jung, Jane

“…Summarises the methodology and results of a study conducted with the aim of identifying and quantifying the types of medications being returned to Otago…”
Get full text

Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma by de Mel, Sanjay, Rashid, Masturah B M, Zhang, Xi Yun, Goh, Jasmine, Lee, Chun Tsu, Poon, Li Mei, Chan, Esther H L, Liu, Xin, Chng, Wee Joo, Chee, Yen Lin, Lee, Joanne, Yuen, Yi Ching, Lim, Jing Quan, Chia, Burton K H, Laurensia, Yurike, Huang, DaChuan, Pang, Wan Lu, Cheah, Daryl Ming Zhe, Wong, Esther Kam Yin, Ong, Choon Kiat, Tang, Tiffany, Lim, Soon Thye, Ng, Siok Bian, Tan, Soo Yong, Loi, Hoi-Yin, Tan, Lip Kun, Chow, Edward K, Jeyasekharan, Anand D

Get full text